Propofol Side Effects
Side effects of Propofol (DIPRIVAN propofol 500mg/50mL injection syringe) that impact work capacity, driving, and recovery for claims professionals, support workers, and care managers. Also known as DIPRIVAN propofol 500mg/50mL injection syringe, DIPRIVAN propofol 1g/100mL injection vial, DIPRIVAN propofol 500mg/50mL injection vial.
Propofol (DIPRIVAN propofol 500mg/50mL injection syringe) is classified as Moderate risk by AllMeds. It is a CNS depressant that can cause drowsiness, impaired coordination, and reduced cognitive function, directly affecting work capacity and return-to-work timelines. It carries a respiratory depression risk, particularly when combined with other CNS depressants. For claims professionals, the side effects of Propofol can impact work capacity, driving fitness, and recovery timelines.
Key Takeaways
- Risk level: Moderate (7 points)
- CNS depressant: Causes sedation, impairs driving, affects cognitive function
- Respiratory risk: Can suppress breathing, especially with other depressants
- Duration limit: 1 days recommended maximum
- Claims action: Assess work capacity impact, check for dangerous interactions, review duration against guidelines
Side Effects That Affect Work Capacity
These side effects of Propofol can directly impact a claimant's ability to work, drive, and perform daily activities:
- Drowsiness and sedation
- Impaired concentration and cognitive function
- Slowed reaction time
- Impaired coordination and balance
- Nausea and constipation
Work capacity certificates should reflect any medication-related restrictions. For safety-sensitive roles (driving, operating machinery, working at heights), these effects may require modified duties or temporary stand-down.
Serious Safety Concerns
These side effects require clinical monitoring and may affect claim management decisions:
- Respiratory depression (slowed or shallow breathing)
- Risk of fatal overdose, especially when combined with other CNS depressants
Dependency and Withdrawal
Propofol carries a risk of physical dependence with regular use. This is a common complicating factor in injury claims:
- Physical dependence with regular use
- Tolerance requiring dose escalation
- Withdrawal symptoms on cessation
Flags for Claims Professionals
- CNS depressant effects may delay return to work, particularly in safety-sensitive roles
- Respiratory depression risk increases significantly with concurrent opioid, benzodiazepine, or gabapentinoid use
- Opioid dependency risk increases with duration beyond guidelines
- Recommended maximum duration: 1 days
Need to assess this medication across your caseload?
Run a full risk assessment to check Propofol side effects, interactions, and compliance across the full medication list.
AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.
No credit card required. No signup for your first 2 questions.
Related Resources
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.